Visalytics
Visalytics
approved EB-2 (NIW)

Scientist

Biotechnologies · China · 2024-10-10

Processing Time
6 days
Decision Date
2024-10-10
Location
New Jersey
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop advanced statistical models using real-world evidence and omics data to identify novel biomarkers for diseases. This work aims to facilitate the development of precision drug therapies and enhance the understanding of cancer, metabolic disorders, and cardiovascular diseases.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research improves the quality and efficiency of medical care for diseases like cancer and cardiovascular disease, benefiting the health of the entire U.S. population.

2 Well-positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. in Biosystems Engineering and has a record of publication in top journals with significant citation impact.

3 Waiver of Job Offer and Labor Certification Met

The petitioner's unique expertise in developing statistical models for precision medicine makes her work highly valuable to U.S. medical science regardless of a specific job offer.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in Biosystems Engineering and her record of 2 first-authored peer-reviewed journal articles in top-tier journals. Her work garnered 57 citations, demonstrating significant influence in the field, and was supported by 2 expert recommendation letters confirming the demand for her expertise. These factors satisfied all three Dhanasar prongs for the National Interest Waiver.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Original Contributions

Similar Cases

Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
88 days 2022-04-01
The petitioner proposes to develop disease transmission models and identify disease-related gene loci to perform in-depth studies on widespread diseases such as heart disease and cancer. Her work aims to provide frameworks for more effective disease control policies and clinical strategies to improve patient outcomes.
View Case

Research Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
New Jersey 367 days 2022-04-05
The petitioner proposes to develop and apply novel statistical methodologies to more accurately evaluate healthcare data and improve treatment efficacy. Her work focuses on characterizing the mechanisms for conditions such as cancer and COVID-19 to improve global treatment strategies.
View Case

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
93 days 2023-03-03
The petitioner proposes to refine diagnostic and therapeutic strategies for complex and chronic diseases by integrating molecular profiling, cellular modeling, and translational biomedical analysis. His work leverages multi-omics data and advanced bioanalysis to deepen the mechanistic understanding of disease progression and treatment response. The endeavor aims to translate biological discoveries into actionable improvements in precision medicine and clinical outcomes.
View Case

Assistant Professor

Biotechnology · China

WeGreened EB-2 (NIW) approved
Louisiana 163 days 2025-10-22
The petitioner proposes to develop AI-powered statistical methods and biostatistical models to analyze large-scale genetic data for predicting chronic disease risks. His work focuses on identifying genetic and environmental factors contributing to conditions such as diabetes, Alzheimer’s, and cardiovascular diseases to advance personalized medicine.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-10-10.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 6 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist